About Company

Tian Shing Trading Co., Ltd (call for short TST) was co-founded in 1960 by three families. In 1983, Mr. DJ Lin, the 2nd generation of the Lin family, was appointed as Managing Director to capitalize on the organizational development and pursue for long term business growth. In 1964, TST became the exclusive agent for Cutter Biological in Taiwan market; and after that, became the sole distributor for Bayer as Cutter Biological was bought by Bayer pharmaceutical company in 1974.

TST is currently the business partner with Sanofi (hemophilia franchise which is currently representing Factor VIII and upcoming Factor XI at appropriate timepoint), and Grifols Therapeutics LLC in Taiwan. We are specializing on the promotions in the therapeutic area of hemophilia, critical care, immune therapy and vaccine, and have been remained the long-term market leader in these sectors.

TST has been shared around 1% market representing a ranking at top 30 companies out of around 1000. Mainly operated in Taiwan with cumulative experiences of 60 years in the marketplace, we have built valuable relationships with key opinion leaders, which has led us to become strong industry & professional networks in the field of hematology, oncology, neurology, hepatology and liver transplantation. Our product portfolio are as follows:

  • Hemophilia
    Ingredient Indication
    Antihemophilic Factor / Factor VIII & XI (recombinant) The control and prevention of bleeding episodes and peri-operative management in patients with hemophilia A & B
  • Critical Care
    Ingredient Indication
    Albumin (Human) Hypoproteinemia、Shock、Burn
    Plasma Protein Fraction (Human) Treatment of Shock
  • Immune Therapy
    Ingredient Indication
    Immune Globulin (Human) Primary Humoral Immunodeficiency (PI)
    Idiopathic Thrombocytopenic Purpura (ITP)
    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    Hepatitis B Immune Globulin (Human) Postexposure prophylaxis for hepatitis B
    RHo (D) Immune Globulin (Human) Prevention of Rh hemolytic disease of the newborn (HDN)
    Tetanus Immune Globulin (Human) Postexposure prophylaxis for Tetanus
    Rabies Immune Globulin (Human) Postexposure prophylaxis for Rabies
  • Vaccine
    Ingredient Indication
    Tetanus and Diphtheria Toxoids Adsorbed In persons 7 years of age and older for Prevention of tetanus and diphtheria.